Hamadeh, I., Youssef, N., & Atrash, S. (2025). Pomalidomide-based vs. Proteasome Inhibitor-based Regimens for Multiple Myeloma: What Is the Optimal Sequence after First Relapse. Medical Research Archives, 13(11). doi:10.18103/mra.v13i11.7081